Matthew Outten

Corporate Officer/Principal at BRIDGEBIO PHARMA, INC.

51 year

Health Technology

Consumer Services

Profile

Matthew Outten is currently Chief Commercial Officer at QED Therapeutics, Inc. and Chief Commercial Officer at BridgeBio Pharma, Inc. Formerly, Mr. Outten was Vice President-Marketing & Marketing Access at Pharmacyclics LLC from 2013 to 2018.
Education includes an undergraduate degree from Hamilton College (New York) and an MBA from the University of Delaware.

Matthew Outten active positions

Companies	Position	Start
BRIDGEBIO PHARMA, INC.	Corporate Officer/Principal	2019-01-31
QED Therapeutics, Inc. QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals	Corporate Officer/Principal	-

All active positions of Matthew Outten

Former positions of Matthew Outten

Companies	Position	End
PHARMACYCLICS, INC.	Corporate Officer/Principal	-

See the detail of Matthew Outten's experience

Training of Matthew Outten

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Matthew Outten's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Pharmacyclics LLC Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis	Health Technology
Hamilton College (New York) Hamilton College (New York) Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Delaware University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
QED Therapeutics, Inc. QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals	Health Technology
BridgeBio Pharma, Inc. BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients	Health Technology